D2-receptor occupancy related to neuroleptical doses, side effects and prolactin levels: a study with IBZM-SPECT

By Schlegel S.   Schloesser R.   Hiemke C.   Nickel O.   Bockisch A.   Hahn K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 327-327

Elsevier

Access to resources Recommend Favorite

Striatal dopamine D₂ receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an ¹²³I-IBZM-SPECT study

By Lomeña Francisco   Catafau Ana   Parellada Eduard   Bernardo Miquel   Font Mireia   Gutiérrez Fernando   Pavía Javier  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Striatal dopamine-2 receptor occupancy as measured with [I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

By Tauscher Johannes   Küfferle Bernd   Asenbaum Susanne   Tauscher-Wisniewski Sitra   Kasper Siegfried  

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 42-49

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine D 3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D 3 receptor antagonist GR103691 with typical and atypical neuroleptics

By Hurley M.J.   Stubbs C.M.   Jenner P.   Marsden C.D.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite

Occupancy of dopamine D₂ receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications

By Frankle W.   Gil R.   Hackett E.   Mawlawi O.   Zea-Ponce Y.   Zhu Z.   Kochan L.   Cangiano C.   Slifstein M.   Gorman J.   Laruelle M.   Abi-Dargham A.  

Psychopharmacology, Vol. 175, Iss. 4, 2004-10 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite